Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Plos One
|
December 24, 2010
A transient transgenic RNAi strategy for rapid characterization of gene function during embryonic development
Bryan C Bjork, Yuko Fujiwara, Shannon W Davis, et al.
British Journal of Clinical Pharmacology
|
April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level
Lin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Cell
|
June 25, 2013
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability
Bryan King, Thomas Trimarchi, Linsey Reavie, et al.
Chemistry & Biology
|
November 5, 2013
Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth
Shivani Garapaty-Rao, Christopher Nasveschuk, Alexandre Gagnon, et al.
Elife
|
January 6, 2016
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
Andrew R Conery, Richard C Centore, Adrianne Neiss, et al.
Elife
|
July 15, 2016
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
Andrew R Conery, Richard C Centore, Adrianne Neiss, et al.
Cell
|
June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
Claudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
Michele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2016
Identification of potent, selective KDM5 inhibitors
Victor S Gehling, Steven F Bellon, Jean-Christophe Harmange, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 9, 2015
Development of methyl isoxazoleazepines as inhibitors of BET
Michael C Hewitt, Yves Leblanc, Victor S Gehling, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Plos One
|
December 24, 2010
A transient transgenic RNAi strategy for rapid characterization of gene function during embryonic development
Bryan C Bjork, Yuko Fujiwara, Shannon W Davis, et al.
British Journal of Clinical Pharmacology
|
April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level
Lin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Cell
|
June 25, 2013
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability
Bryan King, Thomas Trimarchi, Linsey Reavie, et al.
Chemistry & Biology
|
November 5, 2013
Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth
Shivani Garapaty-Rao, Christopher Nasveschuk, Alexandre Gagnon, et al.
Elife
|
January 6, 2016
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
Andrew R Conery, Richard C Centore, Adrianne Neiss, et al.
Elife
|
July 15, 2016
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
Andrew R Conery, Richard C Centore, Adrianne Neiss, et al.
Cell
|
June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
Claudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
Michele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2016
Identification of potent, selective KDM5 inhibitors
Victor S Gehling, Steven F Bellon, Jean-Christophe Harmange, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 9, 2015
Development of methyl isoxazoleazepines as inhibitors of BET
Michael C Hewitt, Yves Leblanc, Victor S Gehling, et al.
Page
of 3